09:23 AM EDT, 05/27/2025 (MT Newswires) -- Health care stocks were edging higher premarket Tuesday as the Health Care Select Sector SPDR Fund ( XLV ) was up 0.9% and the iShares Biotechnology ETF (IBB) rose by 1.8% recently.

Moderna ( MRNA ) shares were up more than 2% after the company said it filed an application with the US Food and Drug Administration for review of its Spikevax formula targeting SARS-CoV-2 variant LP.8.1.

Rocket Pharmaceuticals ( RCKT ) shares fell by more than 63% after the company said the US Food and Drug Administration has placed a clinical hold on the company's mid-stage trial of RP-A501, its drug for Danon disease, after a participant experienced an unexpected serious adverse event and later died from an acute infection.

BeiGene ( ONC ) said the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of its drug Tevimbra in combination with gemcitabine and cisplatin as a first-line treatment for adults with recurrent or metastatic nasopharyngeal cancer. BeiGene ( ONC ) shares were 0.2% lower premarket.